Showing results (681-690 of 843) with videos related to
Sort By:
Pageof 85
Nature Communications|May 17, 2018
Tracking HIV-1 recombination to resolve its contribution to HIV-1 evolution in natural infectionHongshuo Song, Elena E Giorgi, Vitaly V Ganusov, et al.Plos Pathogens|June 4, 2021
Structural and genetic convergence of HIV-1 neutralizing antibodies in vaccinated non-human primatesFangping Cai, Wei-Hung Chen, Weimin Wu, et al.Clinical and Vaccine Immunology : CVI|May 1, 2015
Stable Expression of Lentiviral Antigens by Quality-Controlled Recombinant Mycobacterium bovis BCG VectorsBryan E Hart, Rose Asrican, So-Yon Lim, et al.Science Translational Medicine|April 29, 2016
Initiation of immune tolerance-controlled HIV gp41 neutralizing B cell lineagesRuijun Zhang, Laurent Verkoczy, Kevin Wiehe, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 17, 2016
HIV-1 Envelope Mimicry of Host Enzyme Kynureninase Does Not Disrupt Tryptophan MetabolismTodd Bradley, Guang Yang, Olga Ilkayeva, et al.Plos One|May 12, 2017
Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative womenPeter B Gilbert, Jean-Louis Excler, Georgia D Tomaras, et al.Journal of Virology|August 13, 2024
Comparison of the immunogenicity of mRNA-encoded and protein HIV-1 Env-ferritin nanoparticle designsZekun Mu, Jill Whitley, Diana Martik, et al.Journal of Virology|February 6, 2009
Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variantsM-R Abrahams, J A Anderson, E E Giorgi, et al.Cell Reports|November 3, 2021
Structural basis of glycan276-dependent recognition by HIV-1 broadly neutralizing antibodiesChristopher A Cottrell, Kartik Manne, Rui Kong, et al.Vaccines|April 23, 2025
Computationally Selected Multivalent HIV-1 Subtype C Vaccine Protects Against Heterologous SHIV ChallengeDieter Mielke, Marina Tuyishime, Natasha S Kelkar, et al.Pageof 85